🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Chronic Kidney Disease Stage 3

A Study to Investigate the Safety, Tolerability, and Preliminary Efficacy With AION-301 Administered by Intravenous Infusion Compared With Placebo Administered by Intravenous Infusion Investigational Intervention in Participants Aged 35 to 75 Years of Age With Chronic Kidney Disease (CKD) NCT06721143Phase 1, Phase 22 sites📍 Miami📍 Miami AION Healthspan, Inc. · Tests: AION-301, Placebo Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD) NCT05485961Phase 2, Phase 3566 sites📍 Decatur📍 Huntsville📍 Montgomery CSL Behring · Tests: CSL300, Placebo Phosphate Assessment in Chronic Kidney Disease Patients Study NCT07368946NA1 site📍 Dallas University of Texas Southwestern Medical Center · Tests: Dietary Phosphorus Intake Prospective Analysis of Self Medication With Phytotherapy in Nephropatic Patients. NCT07444515NA4 sites📍 Saint-Benoît📍 Saint-Denis📍 Saint-Paul Centre Hospitalier Universitaire de la Réunion · Tests: series of questions which can change patient care Pharmacokinetics, Pharmacodynamics, Safety and Tolerability Evaluation of CTAP101 Extended-release Capsules in Pediatric Participants NCT07494045Phase 25 sites📍 Kansas City📍 Columbus📍 Philadelphia OPKO Health, Inc. · Tests: CTAP101 A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes) NCT07241390Phase 3566 sites📍 Bahía Blanca📍 Buenos Aires📍 Buenos Aires Eli Lilly and Company · Tests: Orforglipron, Placebo A Study of AND017 to Evaluate Efficacy and Safety in Dialysis-Dependent Chronic Kidney Disease (DD-CKD) Patients With Anemia NCT07494409Phase 31 site📍 Shanghai Kind Pharmaceuticals LLC · Tests: AND017 capsules, ESA Urinary Tubular Biomarkers for Chronic Kidney Disease NCT06732349n/a1 site📍 Rotterdam Erasmus Medical Center · Tests: Urinary tubular test panel A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and China NCT06933472Phase 342 sites📍 Granada Hills📍 San Dimas📍 San Dimas Alebund Pharmaceuticals · Tests: AP301, AP301 Low Dose Reducing Fluid Overload in Heart Failure Patients Using a Non-invasive, Renal Independent System NCT06360380NA10 sites📍 La Jolla📍 San Francisco📍 Minneapolis AquaPass Medical Ltd. · Tests: AquaPass System Effects of Replacing High Protein Foods in People With Chronic Kidney Disease NCT07105670NA1 site📍 West Lafayette Indiana University · Tests: Controlled dietary intervention Phase 3 Clinical Trial With Dapagliflozin in Chronic Kidney Disease in Adolescents and Young Adult Patients NCT05944016Phase 316 sites📍 Heidelberg📍 München📍 München University Hospital Goettingen · Tests: Dapagliflozin, Placebo Closed-Loop Impact on Chronic Kidney Disease in Type 2 Diabetes NCT06925217NA2 sites📍 Lausanne📍 Lausanne Heba Al-Alwan · Tests: CamAPS HX, Standard insulin therapy with CGM Study of 3 Monoclonal Antibodies (REGN9933, REGN7508, and REGN9533) in Adult Participants With End-Stage Kidney Disease on Hemodialysis NCT07759167Phase 11 site📍 Ghent Regeneron Pharmaceuticals · Tests: REGN9933, REGN7508, REGN9533, Heparin ACE Reno, Pico Cell Matrix and Its Effect on eGFR in Chronic Kidney Diseases NCT07187713Phase 41 site📍 Giza Ace Cells Lab Limited · Tests: ACE Reno Multimedia Health Education on Physical Fitness and Physical Activity for Patients With Chronic Kidney Disease NCT07493642NA1 site📍 New Taipei City Fu Jen Catholic University Hospital · Tests: Multimedia Health Education, Standard Education Group A Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD) NCT07624305Phase 3478 sites📍 Huntsville📍 Surprise📍 Tempe AstraZeneca · Tests: Balcinrenone/dapagliflozin, Dapagliflozin, Placebo matching Dapagliflozin, Placebo matching balcinrenone/dapagliflozin Intensification of Blood Pressure Lowering Therapeutics Based on Diuretics Versus Usual Management for Uncontrolled Hypertension IN Patients With Moderate to Severe Chronic Kidney Disease NCT05732727Phase 340 sites📍 Angers📍 Bordeaux📍 Brest University Hospital, Tours · Tests: Antihypertensive algorithm, Standard of care Exercise Activity to Improve Mobility in Patients With CKD and PAD NCT06621264NA3 sites📍 Ferrara📍 Peschiera del Garda📍 Reggio Calabria University Hospital of Ferrara · Tests: EXERCISE TRAINING WITH OR WITHOUT MEDICATION, Control (Standard treatment) A Study of AND017 to Evaluate Efficacy and Safety in Patients With Anemia Due to Non-Dialysis-Dependent Chronic Kidney Disease (NDD-CKD) NCT07487727Phase 31 site📍 Beijing Kind Pharmaceuticals LLC · Tests: AND017, ESA A Phase 3 Study of Efepoetin Alfa for Treatment of Anemia in Patients With Chronic Kidney Disease on Dialysis NCT06466785Phase 358 sites📍 Yerevan📍 Yerevan📍 Yerevan Genexine, Inc. · Tests: Efepoetin Alfa, Darbepoetin Alfa Vitamin K AntagonISt, Factor Xa Inhibitor or No Anticoagulation in Atrial Fibrillation and DIalytic End-stage Renal DiseasE (VISIONAIRE) NCT06402851Phase 46 sites📍 Salvador📍 Brasília📍 Campo Grande Hospital Sirio-Libanes · Tests: Anticoagulant Oral Patiromer and Diet/hrQoL in Chronic Dialysis NCT06858280Phase 31 site📍 Bergamo Mario Negri Institute for Pharmacological Research · Tests: Patiromer 8400 MG [Veltassa], Placebo A Trial of Etelcalcetide in Pediatric Participants With Secondary Hyperparathyroidism and Chronic Kidney Disease on Hemodialysis NCT03633708Phase 343 sites📍 Los Angeles📍 Aurora📍 Kansas City Amgen · Tests: Etelcalcetide, Standard of Care A Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects With Chronic Kidney Disease (CKD) NCT03619850Phase 321 sites📍 Hollywood📍 Detroit📍 Kansas City AMAG Pharmaceuticals, Inc. · Tests: Ferumoxytol, Iron sucrose A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CTX001 in Healthy Adults. NCT07577817EARLY Phase 11 site📍 Melbourne Cajal Therapeutics Inc. · Tests: CTX001 With and Without Iron, CTX001 With Iron, CTX001 Multiple Dose, Placebo With and Without Iron, Placebo With Iron Evaluation of the Effect of a Daily Dose of Wakame Seaweed on Reducing Circulating Concentrations of Advanced Glycation End Products in Patients With Stage III Chronic Kidney Disease NCT07729683NA1 site📍 La Rochelle Groupe Hospitalier de la Rochelle Ré Aunis · Tests: Consumption of wakame Equol and Vascular Function in Women With Chronic Kidney Disease NCT07194590Phase 21 site📍 Aurora University of Colorado, Denver · Tests: Equol, Placebo Prediction of Peripheral Neuropathy With Functional Testing NCT06933108n/a1 site📍 Le Mans Université catholique de l'Ouest Safety and Efficacy of SC101 Via Perirenal Fat Injection for Resistant Hypertension in Patients With Moderate to Severe Chronic Kidney Disease NCT07483372Phase 11 site📍 Suzhou The First Affiliated Hospital with Nanjing Medical Universi… · Tests: SC101
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy